Annals of Chinese Medicine https://heyttu.com/journals-submission/index.php/acm <p><a href="https://heyttu.com/journals-submission/index.php/acm"><strong><em>Annals of Chinese Medicine</em> </strong></a>(ACM) is an interdisciplinary multi-lingual open access journal focusing on clinical studies and basic researches in the field of Chinese Medicine. It aims to be a leading journal to present research advances and achievements in this field and to promote the blending among acupuncture, herbal medicine, complementary and alternative medicine (CAM), and bio-medicine. <a href="https://heyttu.com/journals-submission/index.php/acm"><strong><em>Annals of Chinese Medicine</em></strong></a> covers all aspects of Chinese Medicine, including acupuncture, moxibustion, herbal medicine and other forms of CAM approaches, e.g. mind-body medicine, diet, Taichi, Qigong, meditation, as well as their integration with the conventional medicine.</p> <p> </p> Heyttu Academic Publishing en-US Annals of Chinese Medicine 2597-0828 <p><!-- wp:paragraph --></p> <p><strong><a href="https://heyttu.com/journals-submission/index.php/acm/management/settings/anncm.dk"><em>Annals of Chinese Medicine</em></a></strong> applys the Hybrid method with Open Access (CC BY-NC-ND 4.0) and traditional publishing method. Authors need to choose either with Open Access or Traditional Publishing. <a href="https://heyttu.com/journals-submission/index.php/acm/about/submissions">Read more </a></p> <p><!-- /wp:paragraph --></p> Acupuncture treatment for acute icteric hepatitis https://heyttu.com/journals-submission/index.php/acm/article/view/12 <p><strong>Objective:</strong> To observe the clinical efficacy of acupuncture treatment for acute icteric hepatitis.</p> <p><strong>Method:</strong> Forty patients with acute icteric hepatitis were randomized into a treatment group and a control group (20 in each group). Oral liver-protecting medicine was administrated for the control group. In the treatment group, acupuncture with Yinlingquan-SP9, Yanglingquan-GB34, Zhusanli-ST36, Sanyinjiao-SP6, and Taichong-LR3 was added. The clinical efficacies and serum liver enzymes, including (TB, ALT, and GGT) were evaluated.</p> <p><strong>Result: </strong>The total effective rate was 94.7% in the treatment group and 85.0% in the control group respectively, which differed significantly different(P&lt;0.05). The liver function indexes decreased significantly in both groups after treatment (P&lt;0.01). The indicators of the treatment group were significantly lower than those of the control group after treatment (P&lt;0.05).</p> <p><strong>Conclusion:</strong> Acupuncture combined with hepatoprotective drugs could be an effective method to treat acute jaundice hepatitis and showed better effectiveness than the single use of the conventional therapy.</p> Xue Mei Wan Jing Chen Tian Hong Zhang Xue Lei Zhou Copyright (c) 2021 Xue Mei Wan, Jing Chen, Tian Hong Zhang, Xue Lei Zhou https://creativecommons.org/licenses/by-nc-sa/4.0 2021-09-29 2021-09-29 2021 2 10.46949/acm.2021.2.1 Idiopathic mesenteric phlebosclerosis (IMP) with sepsis and death: a case study https://heyttu.com/journals-submission/index.php/acm/article/view/13 <p>Idiopathic mesenteric phlebosclerosis (IMP) is a rare clinical manifestation of ischemic enteropathy. There are no specific manifestations in the early stages. Digestive symptoms only present in the advanced stage. Diagnosis relies on extensive calcification of the mesenteric venule and extensive intestinal wall thickening via computed tomography (CT) scanning. A 50 years old Chinese woman who had taken herbal medicine for three years was diagnosed with IMP. All treatment after admission was in vain and she died 30 days thereafter. Therefore, when a patient with long-term oral intake of herbal medicine, which contains geniposde, presents with unknown ischemia, abdominal pain, mucinous stools, bloody stools, attention should be paid to screen IMP.&nbsp;</p> Xue Lei Zhou Xue Mei Wan Jing Chen Zi Yan Xie Copyright (c) 2021 Xue Lei Zhou, Xue Mei Wan, Jing Chen, Zi Yan Xie https://creativecommons.org/licenses/by-nc-sa/4.0 2021-10-25 2021-10-25 2021 2 5 5 10.46949/acm.2021.2.2